
The company completed construction at the site in just 15 months despite the COVID-19 pandemic, with production starting in November 2020. The plant is meant to create a solid production base for high-quality borosilicate glass tubing in the local Chinese market. The tubing is for pharma containers that store vaccines (e.g., against COVID-19) and other drugs.
“Right on schedule with our planning, we have doubled our melting capacity. It’s another big milestone for pharma tubing in China. The expanded infrastructure will enable a reliable local supply of glass tubing, which is needed urgently to serve the increased demand for pharmaceutical packaging,” Patrick Markschläger, EVP of Schott’s Business Unit Tubing, said in a news release.
Get the full story on our sister site Pharmaceutical Processing World.